Risk Evaluation and Mitigation Strategy Program

**Semantic type:** Functional Concept

**Definition:** A drug safety program of the U.S. Food and Drug Administration (FDA), which can be required for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks.

**Synonyms:** - Risk Evaluation and Mitigation Strategy (REMS)